Azitra, Inc. (AZTR)
NYSEAMERICAN: AZTR · Real-Time Price · USD
0.2619
+0.0069 (2.71%)
At close: Jun 26, 2025, 4:00 PM
0.2619
0.00 (0.00%)
Pre-market: Jun 27, 2025, 7:20 AM EDT
Azitra Revenue
Azitra had revenue of $7.50K in the twelve months ending March 31, 2025, down -98.69% year-over-year. In the year 2024, Azitra had annual revenue of $7.50K, down -98.91%.
Revenue (ttm)
$7.50K
Revenue Growth
-98.69%
P/S Ratio
241.38
Revenue / Employee
$625
Employees
12
Market Cap
4.51M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.50K | -678.50K | -98.91% |
Dec 31, 2023 | 686.00K | 402.00K | 141.55% |
Dec 31, 2022 | 284.00K | 174.00K | 158.18% |
Dec 31, 2021 | 110.00K | -315.00K | -74.12% |
Dec 31, 2020 | 425.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
AZTR News
- 9 days ago - Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome - PRNewsWire
- 16 days ago - Azitra, Inc. Announces Presentation at the 2025 BIO International Convention - PRNewsWire
- 4 weeks ago - Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash - PRNewsWire
- 6 weeks ago - Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash - PRNewsWire
- 6 weeks ago - Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates - PRNewsWire
- 2 months ago - Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025 - PRNewsWire
- 2 months ago - Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline - PRNewsWire
- 3 months ago - Azitra to Present at Microbiome Times Partnering Forum - PRNewsWire